Pat Burnell was a key instigator in setting up the DDL Conference over 25 years ago. Her vision was for a conference that is accessible and inclusive to all. She was passionate about aerosol science and in her own words “those who do the research should present their work, not their stuffy old boss or academic supervisors”.
This award recognises the vision of Pat Burnell and has been designed to encourage junior researchers from either academia or industry to present their work at the DDL Conference.
Shortlisted Authors will be asked to deliver a 10 minute oral presentation in the main auditorium as well as presenting a poster at the conference. The award will be given to the researcher who, in the opinion of the DDL Organising Committee, has not only produced the best research but has shown that they understand and can explain their work.
The winner of the Pat Burnell New Investigator Award receives a certificate and £500.00 prize funds.
This award is separate from the Best Academic Poster award (£250) and the Best Industry Poster award (£250) which are also judged during the DDL Conference, so we recommend supervisors to encourage their students to apply.
To be eligible for this award, you should submit your aerosol science research topic while studying for your degree (BSc, MSc, MD, PhD, other postgraduate qualification) or up to 3 years post completion.
You will need to submit an accompanying letter of support from your supervisor.
If you are eligible and wish to be considered for the award, you must submit an abstract to the DDL Conference ticking the box to be considered for The Pat Burnell New Investigator Award before the deadline of 28th July 2017.
The DDL Organising Committee shortlist the best abstracts and will contact the authors during October.
Areas of particular interest for DDL2017 include:
Inhaled Therapy in Special Populations
Delivery of aerosol medicines to patients at the extremes of life (neonates, paediatrics, the elderly), patients with poor capacity to use inhalers, concomitant diseases, ventilated patients, etc.
Emerging Therapeutics and Novel Respiratory Medicines
New and repurposed drugs, novel formulations and drug combinations, generic inhalers and innovative inhaled treatments based on advances in clinical science and respiratory medicine.
Inhalation Devices and Aerosol Science
Novel inhaler technology, new devices and performance enhancements. New or novel methods for aerosol generation, measurement and characterisation.
Modelling and Simulations in Inhalation Science
The application of in silico methods to any aspects of inhaled drug development, including discovery and lead compound optimisation, molecular and particulate interactions, aerosol dynamics, lung deposition and pharmacokinetics.
It is essential that you adhere to the Abstract Guidelines and only use the Abstract Template when submitting an abstract to DDL2017. No other versions will be accepted.